Cetera Investment Advisers

Position in PYXS — Pyxis Oncology, Inc.

CIK 1666741 SCHAUMBURG, IL

Position in PYXS

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$39,799

+$8,450 QoQ

Shares Held

27,260

0.0% QoQ

Ownership

0.043%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#41

of 78 holders

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Cetera Investment Advisers holds $158,169,500 across 104 Biotechnology names. PYXS ranks #85 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	72,633	$32,433,539
2	REGN	Regeneron Pharmaceuticals, Inc.	16,006	$12,366,875
3	ALNY	Alnylam Pharmaceuticals, Inc.	23,173	$7,667,250
4	EXEL	Exelixis, Inc.	169,881	$7,286,196
5	IBRX	ImmunityBio, Inc.	946,709	$7,261,258
6	OCUL	Ocular Therapeutix, Inc	764,615	$6,476,289
7	VKTX	Viking Therapeutics, Inc.	189,028	$6,150,971
8	INSM	INSMED Inc	34,356	$5,617,893

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$39,799	27,260	0.0%	Shares	Sole	2026-05-13
2025-12-31	$31,349	27,260	-1.8%	Shares	Sole	2026-02-17
2025-09-30	$61,627	27,760	-3.5%	Shares	Sole	2025-11-14
2025-06-30	$31,636	28,760	+3.2%	Shares	Sole	2025-08-08
2025-03-31	$27,302	27,860	+3.7%	Shares	Sole	2025-05-06
2024-12-31	$41,901	26,860	+3.9%	Shares	Sole	2025-02-14
2024-09-30	$94,906	25,860	-8.0%	Shares	Sole	2024-11-13
2024-06-30	$93,044	28,110	-4.3%	Shares	Sole	2024-08-22
2024-03-31	$125,073	29,360	+44.2%	Shares	Sole	2024-05-24
2023-12-31	$36,651	20,362	+5.7%	Shares	Sole	2024-02-13
2023-09-30	$38,327	19,260	+5.5%	Shares	Sole	2023-11-14
2023-06-30	$46,745	18,260	—	Shares	Sole	2023-08-10
No filing history on record for this holder in this stock.